Literature DB >> 7690029

Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus.

S Cociancich1, A Ghazi, C Hetru, J A Hoffmann, L Letellier.   

Abstract

Insect defensins are cationic, cysteine-rich peptides (approximately 4 kDa) that appear after bacterial challenge or injury in the hemolymph of insects belonging to a large variety of orders. These peptides possess anti-Gram-positive activity and participate in the potent antibacterial defense reactions of insects. Using recombinant insect defensin and the strain Micrococcus luteus as a test organism, we have investigated the mode of action of this peptide. We show that defensin disrupts the permeability barrier of the cytoplasmic membrane of M. luteus, resulting in a loss of cytoplasmic potassium, a partial depolarization of the inner membrane, a decrease in cytoplasmic ATP, and an inhibition of respiration. Potassium loss is inhibited below the order-disorder transition of the lipid hydrocarbon chains. It is also inhibited by divalent cations and by a decrease in the membrane potential below a threshold of 110 mV. We propose that these permeability changes reflect the formation of channels in the cytoplasmic membrane by defensin oligomers. This proposal is supported by patch-clamp experiments that show that insect defensins form channels in giant liposomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Orientation of cecropin A helices in phospholipid bilayers determined by solid-state NMR spectroscopy.

Authors:  F M Marassi; S J Opella; P Juvvadi; R B Merrifield
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  A gene encoding a sphingolipid biosynthesis enzyme determines the sensitivity of Saccharomyces cerevisiae to an antifungal plant defensin from dahlia (Dahlia merckii).

Authors:  K Thevissen; B P Cammue; K Lemaire; J Winderickx; R C Dickson; R L Lester; K K Ferket; F Van Even; A H Parret; W F Broekaert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  The antifungal protein from Aspergillus giganteus causes membrane permeabilization.

Authors:  T Theis; M Wedde; V Meyer; U Stahl
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

Review 4.  [Wound healing by steril fly larvas: basic mechanical, biochemical and microbiological principles].

Authors:  Martin Grassberger; Christa Frank
Journal:  Wien Med Wochenschr       Date:  2003

5.  The insect defensin lucifensin from Lucilia sericata.

Authors:  Mads Kristian Erlin Nygaard; Anders Schou Andersen; Hans-Henrik Kristensen; Karen Angeliki Krogfelt; Peter Fojan; Reinhard Wimmer
Journal:  J Biomol NMR       Date:  2012-03       Impact factor: 2.835

Review 6.  Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.

Authors:  E Andrès
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-01       Impact factor: 3.267

7.  Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides.

Authors:  S P Koo; A S Bayer; M R Yeaman
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Molecular immune responses of the mosquito Anopheles gambiae to bacteria and malaria parasites.

Authors:  G Dimopoulos; A Richman; H M Müller; F C Kafatos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

9.  Mode of action of linenscin OC2 against Listeria innocua.

Authors:  C Boucabeille; L Letellier; J M Simonet; G Henckes
Journal:  Appl Environ Microbiol       Date:  1998-09       Impact factor: 4.792

10.  Multilayer polyelectrolyte films functionalized by insertion of defensin: a new approach to protection of implants from bacterial colonization.

Authors:  O Etienne; C Picart; C Taddei; Y Haikel; J L Dimarcq; P Schaaf; J C Voegel; J A Ogier; C Egles
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.